TFSA: 3 Top Stocks to Buy With a $6,500 Contribution

Are you wondering what to do with your $6,500 TFSA contribution this year? Here are three quality stock ideas that could work out nicely.

| More on:
TFSA and coins

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Every Canadian gets an additional chance to contribute to their TFSA (Tax-Free Savings Account) in 2023. This year, the CRA (Canada Revenue Agency) increased the annual contribution limit by 8.3% to $6,500!

The TFSA is the ideal place to save and invest

The TFSA is a great mechanism for Canadians to save and invest. All investment income (interest, dividends, or capital gains) earned in the TFSA is totally tax free. Unlike the RRSP (Registered Retirement Savings Plan), any withdrawal from the TFSA is also tax free.

If you aren’t investing through a registered savings plan like the TFSA, you could be losing as much as 10-25% of your investment return just by paying tax. That is why it is never too late to use the TFSA to maximize its tax savings advantages. If I was looking to invest that fresh $6,500 contribution, here are three stocks I’d consider right now.

A top consumer products stock

If you are looking for a unique blend of income and growth, Jamieson Wellness (TSX:JWEL) is a stock to put on your TFSA radar. It has some of the best brands for wellness, nutrition, vitamins, and supplements in Canada. Go to any grocery store, and Jamieson’s vitamin products are the first you will see.

Over the past several years, Jamieson has benefited from expansion into China. Most recently, it completed an acquisition that will make it a major supplement and vitamin player in the U.S. (a huge addressable market). When I think about COVID-19 and all the other viruses flying around, immune-support is on the top of mind for consumers. Jamieson Wellness should be a direct winner from this trend.

This stock pays a nice 1.8% dividend. It has increased its dividend by a 22% compounded annual rate since its IPO (initial public offering) in 2016. For a stock growing earnings by the mid-teens and a dividend growing even faster, this is an interesting TFSA stock.

An undervalued financial stock

Brookfield Corporation (TSX:BN) did not perform as well as expected in 2022. Its stock is down 15% over the past year. However, this could be an attractive opportunity.

Brookfield is a complex organization. It manages stakes in a broad array of businesses (infrastructure, real estate, renewables, insurance, private equity, and debt) and it also manages money for large institutions.

At times, this can lead the market to underestimate its overall value. Right now, it trades nearly 25% below its estimated value. Management (who are heavily invested alongside shareholders) are incentivized to unlock value.

One could suspect substantial share buybacks may occur this year. The company still has plenty of opportunities to grow, so patient TFSA investors could end up doing very well.

A top TFSA stock for income

If you are just looking for some solid dividends and stable growth, TELUS (TSX:T) is a great stock for a TFSA. TELUS is the second-largest telecommunications provider in Canada. This business generates predictable mid- to high single-digit earnings growth. Likewise, it has grown its annual dividend by around 7-8% for a more than a decade.

TELUS is nearing the end of a large investment cycle. After, it is expecting to earn an outsized level of excess cash. If management does what it says, that should come back to shareholders in the form of 7-10% annual dividend increases for a few years to come.

TELUS also has some optional growth through its digital businesses in customer experience, agri-tech, and virtual healthcare. With a 4.9% dividend yield, it looks like decent value for a TFSA addition.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Robin Brown has positions in Brookfield and Jamieson Wellness. The Motley Fool recommends Brookfield, Brookfield Corporation, and TELUS. The Motley Fool has a disclosure policy.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »